Lupin`s Generic Eslicarbazepine Acetate Receives Approval in the U.S.
Hetero's Generic Eslicarbazepine Acetate Receives Approval in US
Alkem's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
Aurobindo's Generic Eslicarbazepine Acetate Receives Approval in the U.S.
Sph Shanghai Zhongxi Pharma`s Generic Eslicarbazepine Acetate Receives Approval in US
For over a decade, BIAL and Eisai have had an agreement in place for Eisai to market, promote, and distribute eslicarbazepine acetate in Europe. Following the end of this partnership, BIAL will take the lead for the ongoing marketing, promotion and distribution in Europe. This move reinforces its continued commitment to and ongoing investment in neurological conditions.
Dr Reddys Labs Ltd's Generic Eslicarbazepine Acetate Receives Tentative Approval In US
SPH Shanghai Zhongxi`s Eslicarbazepine Acetate Receives Supplemental Approval in US
Alkem Labs's Generic Eslicarbazepine Acetate Receives Tentative Approval in US